title: Subcutaneous erythropoietin: a comparison of daily and thrice weekly administration.
authors.affiliation: Department of Nephrology, University Hospital, Nîmes, France.
authors.forename: C
authors.initials: C
authors.lastname: Granolleras
authors.forename: B
authors.initials: B
authors.lastname: Branger
authors.forename: S
authors.initials: S
authors.lastname: Shaldon
authors.forename: B
authors.initials: B
authors.lastname: Nonnast-Daniel
authors.forename: K M
authors.initials: KM
authors.lastname: Koch
authors.forename: M
authors.initials: M
authors.lastname: Pollok
authors.forename: C A
authors.initials: CA
authors.lastname: Baldamus
mesh_terms: D000328:Adult; D000740:Anemia / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000008:administration & dosage* / Q000276:immunology; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000276:immunology; D006435:Renal Dialysis
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin